Want to see GB:CRTA full AI Analyst Report?
Top Page
Cirata
(LSE:CRTA)
Select Model
Select Model
Rating:46Neutral
Price Target:
12.00 p
▼(-4.91% Downside)
Action:Reiterated
Date:09/11/26
The score is held back primarily by ongoing losses and continued negative free cash flow despite strong revenue acceleration and very high gross margins. Technicals also weigh on the outlook, with the stock in a clear downtrend and weak momentum indicators. Valuation is constrained by negative earnings (negative P/E) and no provided dividend yield.
Positive Factors
Revenue Acceleration
The sharp 2025 revenue acceleration indicates improving customer adoption and stronger commercial traction for Cirata’s software and services. If sustained, expanding scale can support broader market reach, improve operating leverage, and provide a foundation for future earnings growth.
Negative Factors
Persistent Unprofitability
Material net and operating losses show that revenue growth has not yet translated into a sustainable profit engine. Continued losses can restrict investment flexibility, require further funding, and make the company more sensitive to execution setbacks while it works to align costs with its expanding revenue base.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Acceleration
The sharp 2025 revenue acceleration indicates improving customer adoption and stronger commercial traction for Cirata’s software and services. If sustained, expanding scale can support broader market reach, improve operating leverage, and provide a foundation for future earnings growth.
Read all positive factors
Cirata (CRTA) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£20.14M
Dividend YieldN/A
Average Volume (3M)262.39K
Price to Earnings (P/E)―
Beta (1Y)<0.01
Revenue Growth48.92%
EPS Growth45.58%
CountryUK
Employees69
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)-0.06
Shares Outstanding162,759,630
10 Day Avg. Volume211,119
30 Day Avg. Volume262,387
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)2.99
Price to Sales (P/S)2.52
P/FCF Ratio-3.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.01
Revenue Forecast (FY)£12.00M
Cirata Business Overview & Revenue Model
Company Description
Operating internationally across North America, Europe, and China, Cirata plc – previously known as WANdisco plc until its rebranding in October 2023 – specializes in creating and supplying collaboration software. A central offering is its WANdisc...
How the Company Makes Money
Cirata primarily makes money by selling enterprise software subscriptions and related commercial offerings around its data flow and data management products (notably its enterprise distribution of Apache NiFi and associated management/governance c...
Cirata Earnings Call Summary
Earnings Call Date:Sep 03, 2025
(Q2-2025)
| % Change Since: |
Next Earnings Date:Apr 07, 2027
Earnings Call Sentiment Neutral
Cirata's earnings call indicates strong revenue and bookings growth, effective cost management, and strategic partnerships, paired with challenges in sales execution and customer acquisition. While there are significant achievements, the need for improved execution in certain areas tempers overall enthusiasm.Positive Updates
Significant Revenue Growth
Revenue for the first half of 2025 rose to $4.8 million, up from $3.4 million a year ago, marking an increase of over 40%.
Negative Updates
Disappointing Q2 Performance
Q2 results were below expectations, failing to demonstrate consistent quarterly progress.
Read all updates
Q2-2025 Updates
Positive
Negative
Significant Revenue Growth
Revenue for the first half of 2025 rose to $4.8 million, up from $3.4 million a year ago, marking an increase of over 40%.
Read all positive updates
Company Guidance
In the recent call, Cirata reported significant progress in the first half of fiscal year 2025, with revenues rising over 40% to $4.8 million from $3.4 million a year ago, and bookings increasing by 58% to $3.8 million. The company achieved a notable reduction in cash overheads, from $11.8 million to $8.5 million, contributing to the halving of its adjusted EBITDA loss from $8.6 million to $4 million. Cirata ended June with a cash plus receivables position of $7.4 million. The data integration segment, a core focus for Cirata, showed robust growth, with bookings in this area soaring over 200% year-on-year to $3.1 million. Despite a disappointing Q2, the first half data integration bookings were up significantly, and the company successfully signed 20 contracts, including an enterprise-wide license with a top retailer. Strategic moves, such as divesting DevOps assets to BlueOptima, resulted in up to $3.5 million in cash and allowed Cirata to concentrate on its data integration business. Additionally, the appointment of Dominic Arcari as Chief Revenue Officer is expected to enhance sales execution. The outlook remains positive, with expectations of continued triple-digit growth in data integration and no further working capital fundraise needed in FY '25.Cirata Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
62
Positive
Cash Flow
34
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.12M | 7.68M | 6.70M | 9.69M | 7.31M |
| Gross Profit | 11.18M | 7.14M | 6.06M | 8.99M | 6.65M |
| EBITDA | -4.75M | -14.39M | -36.69M | -39.13M | -32.47M |
| Net Income | -7.26M | -13.51M | -36.48M | -29.61M | -37.59M |
Balance Sheet | |||||
| Total Assets | 13.34M | 14.92M | 23.11M | 26.54M | 42.19M |
| Cash, Cash Equivalents and Short-Term Investments | 3.98M | 9.73M | 18.25M | 19.11M | 27.76M |
| Total Debt | 467.17K | 889.00K | 795.00K | 539.00K | 1.82M |
| Total Liabilities | 3.10M | 5.35M | 6.50M | 8.64M | 7.76M |
| Stockholders Equity | 10.24M | 9.57M | 16.61M | 16.56M | 34.42M |
Cash Flow | |||||
| Free Cash Flow | -8.35M | -14.88M | -30.67M | -27.70M | -34.00M |
| Operating Cash Flow | -8.26M | -14.77M | -30.60M | -27.50M | -28.23M |
| Investing Cash Flow | 2.93M | -107.00K | -43.00K | -158.00K | -5.76M |
| Financing Cash Flow | -575.83K | 6.44M | 29.10M | 19.48M | 40.79M |
Cirata Technical Analysis
Neutral
12.62
Price Trends
14.39
Negative
16.02
Negative
17.09
Negative
Market Momentum
-0.65
Negative
48.12
Neutral
45.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRTA, the sentiment is Neutral. The current price of 12.62 is below the 20-day moving average (MA) of 12.71, below the 50-day MA of 14.39, and below the 200-day MA of 17.09, indicating a neutral trend. The MACD of -0.65 indicates Negative momentum. The RSI at 48.12 is Neutral, neither overbought nor oversold. The STOCH value of 45.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CRTA.
Cirata Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £193.25M | 142.24 | 4.16% | 0.52% | 19.82% | -60.20% | |
71 Outperform | £100.42M | 14.21 | 5.57% | ― | -1.34% | 20.88% | |
68 Neutral | £202.16M | 82.87 | 5.22% | 0.79% | 19.00% | -53.85% | |
64 Neutral | £145.10M | 15.96 | 8.80% | 2.52% | 3.82% | -18.43% | |
62 Neutral | £132.41M | -53.12 | -29.18% | ― | 47.75% | -308.39% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | £20.14M | -2.77 | -90.39% | ― | 48.92% | 45.58% |
* Technology Sector Average
GB:CRTA
Cirata
12.85
-11.65
-47.55%
GB:ACSO
accesso Technology
309.00
-130.00
-29.61%
GB:DOTD
Dotdigital
48.05
-15.38
-24.24%
GB:ELCO
Eleco
229.00
66.53
40.95%
GB:NET
Netcall
118.50
4.47
3.92%
GB:AOM
ActiveOps plc
196.00
16.00
8.89%
Cirata Corporate Events
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Cirata boosts balance sheet as Symphony platform gains first customer and pipeline grows
Positive
Jul 24, 2026
Cirata reported an unaudited second-quarter trading update showing closing annual contract value of $5.3 million, billings of $0.5 million, and remaining contract billings of $5.7 million, while reaffirming its outlook for achieving cash flow brea...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and ComplianceShareholder Meetings
Cirata raises £5.4m via AIM share issue after shareholder approval
Positive
Jul 24, 2026
Cirata has secured shareholder approval at a general meeting to issue 36,310,971 new ordinary shares at 15 pence each, raising about £5.4 million in gross proceeds through a fundraising on London’s AIM market. The company has also estab...
Private Placements and FinancingShareholder Meetings
Cirata seeks shareholder approval for £5.4m AIM fundraising and share issue
Neutral
Jun 29, 2026
Cirata has published a circular convening a general meeting to secure shareholder approval for the issue of 36,310,971 new ordinary shares, following a fundraising first announced on 26 June 2026. The fundraising, priced at 15 pence per share and ...
Delistings and Listing ChangesPrivate Placements and Financing
Cirata raises £5.4m through retail offer and share placing
Neutral
Jun 29, 2026
Cirata plc has completed a retail offer that raised approximately £0.32 million through the issuance of 2,155,622 new ordinary shares at 15 pence each, following a broader fundraising announced earlier in June. Combined with the placing and s...
Business Operations and StrategyPrivate Placements and Financing
Cirata Raises £5.1m in Oversubscribed AIM Fundraising
Positive
Jun 26, 2026
Cirata has completed an oversubscribed placing and subscription, raising £5.1 million through the issue of 34.2 million new shares, equivalent to about 27% of its existing share capital. The new equity was sold at 15 pence per share, an 18.9%...
Business Operations and StrategyPrivate Placements and FinancingShareholder Meetings
Cirata Launches Discounted Retail Share Offer to Support Growth Plans
Positive
Jun 25, 2026
Cirata has launched a conditional retail offer to raise up to £380,000 by issuing new ordinary shares at 15 pence, an 18.9% discount to the prior closing mid-price, via platform provider RetailBook. The retail tranche complements a simultaneo...
Business Operations and StrategyPrivate Placements and FinancingShareholder Meetings
Cirata to Raise £4.6m to Accelerate AI Data Platform Growth
Positive
Jun 25, 2026
Cirata plans to raise about £4.6 million through a placing and subscription of new shares at 15 pence, alongside a retail offer of up to £0.38 million, representing roughly 24% of its existing share capital. Directors and senior employee...
Business Operations and StrategyProduct-Related Announcements
Cirata Deepens IBM Alliance With OEM Deal for Symphony Data Platform
Positive
Jun 16, 2026
Cirata has signed a revised original equipment manufacturer agreement with IBM under which its Cirata Symphony data orchestration product will be embedded and sold as Cirata Symphony for IBM Big Replicate. The move embeds Cirata more deeply into I...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.